EMPRISE Trademark

Trademark Overview

On Thursday, December 21, 2017, a trademark application was filed for EMPRISE with the United States Patent and Trademark Office. The USPTO has given the EMPRISE trademark a serial number of 79229786. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, May 27, 2025. This trademark is owned by Boehringer Ingelheim International GmbH. The EMPRISE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of diabetes, cardiovascular diseases, chronic kidney disease and epidemiological studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
emprise

General Information

Serial Number79229786
Word MarkEMPRISE
Filing DateThursday, December 21, 2017
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, May 27, 2025
Registration Number5663596
Registration DateTuesday, January 29, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements

Goods and ServicesMedical and scientific research in the field of diabetes, cardiovascular diseases, chronic kidney disease and epidemiological studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 6, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Friday, April 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 5, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 9, 2018NON-FINAL ACTION WRITTEN
Tuesday, April 10, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, April 28, 2018REFUSAL PROCESSED BY IB
Tuesday, September 25, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 6, 2018ASSIGNED TO EXAMINER
Tuesday, April 10, 2018APPLICATION FILING RECEIPT MAILED
Thursday, April 12, 2018REFUSAL PROCESSED BY MPU
Thursday, April 12, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 25, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 25, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 24, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 24, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, November 9, 2018NOTIFICATION PROCESSED BY IB
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 29, 2019REGISTERED-PRINCIPAL REGISTER
Monday, April 29, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, May 23, 2019FINAL DISPOSITION PROCESSED
Monday, January 29, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, January 29, 2025TEAS SECTION 71 RECEIVED
Monday, May 26, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 27, 2025REGISTERED-SEC.71 ACCEPTED
Tuesday, May 27, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, May 24, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 14, 2019FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

emprise medical field research scientific providing information trials studies clinical pharmaceuticals